Skip to content

Revvity RVTY Human Health — Product Revenue

Discontinued — last reported Q3 '16

Similar metrics at other companies

Baxter International logo
BAXHospital Products — Net Revenue
$1.7B+7.3%
Clorox logo
CLXHealth and Wellness — Net Sales
$629M-0.2%
Zimmer Biomet Holdings logo
ZBHOperating Segments — Product Revenue
$979.3M+1.0%
Guardant Health logo
GHReportable Segment — Revenue
$301.67M+48.3%
STERIS logo
STEHealthcare — Total revenues
$1.03B+9.5%
Zoetis logo
ZTSContract manufacturing & human health — Revenue
$23M-23.3%

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$11.16B-22.9%
Enterprise value$14.24B-13.7%
P/E46.5×-4.0×
P/S3.8×-1.4×

Profitability

See full
Gross margin48.5%
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:SalesRevenueNet.

The official record: Revvity’s 10-Q, filed November 8, 2016, on SEC EDGAR. View the filing →

Questions, answered.

What does human health — product revenue mean?
The total net sales revenue generated by the Human Health segment.
How do you interpret human health — product revenue?
Higher revenue signals strong market adoption and demand for the segment's products, while lower revenue may indicate market saturation or competitive pressure.
How does human health — product revenue compare across companies?
Standard segment revenue metric used across all public companies with divisional reporting.